| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 07/02/2008 | CN101213198A 1-[2',3'-dideoxy-3'C-(hydroxymethyl)-beta-D-erythro-pentofuranosyl] cytosine derivatives as HIV inhibitors |
| 07/02/2008 | CN101213193A Mono-lysine salts of azole compounds |
| 07/02/2008 | CN101213179A 2,4-diamino-pyrimidines used as Aurora inhibitors |
| 07/02/2008 | CN101212987A Self-sterilizing products |
| 07/02/2008 | CN101212970A Combination of HCV protease inhibitors with a surfactant |
| 07/02/2008 | CN101212961A HMB compositions and uses thereof |
| 07/02/2008 | CN101212957A Novel pharmaceutical sustained release compositions and processes thereof |
| 07/02/2008 | CN101210921A Rabbit anti-big gerbil immune serum |
| 07/02/2008 | CN101210046A Antifungal protein and usage thereof |
| 07/02/2008 | CN101210023A Novel cephalosporin derivatives |
| 07/02/2008 | CN101210022A Cephalosporin |
| 07/02/2008 | CN101210021A Cephalosporin compounds |
| 07/02/2008 | CN101210020A Cephalosporin compound |
| 07/02/2008 | CN101210012A Novel isoflavone nicotinic acid ester derivatives, preparing method and use thereof |
| 07/02/2008 | CN101209995A 5-amidopyrazole derivatives, preparation method and use thereof |
| 07/02/2008 | CN101209351A Ankara vaccinia virus genetic engineering vaccine for pig replication and respiration complex |
| 07/02/2008 | CN101209345A Animal genetic engineering interferon alpha and gamma composite preparations and production method and clinical application thereof |
| 07/02/2008 | CN101209332A Medicinal composition for treating ovary inflammation caused by tubercle bacillus affection |
| 07/02/2008 | CN101209315A Chinese medicinal injection with antimicrobial and anti-inflammation, milk-smoothing and mass-dissipating efficacy |
| 07/02/2008 | CN101209311A Chinese medicinal injection with heat-clearing and detoxication, detumescence and mass-dissipating efficacy |
| 07/02/2008 | CN101209307A Chinese medicinal oral liquid with heat-clearing and detoxication, dampness-eliminating and dysentery-stopping efficacy |
| 07/02/2008 | CN101209306A Chinese medicine granule for treating colibacillosis of avian |
| 07/02/2008 | CN101209305A Chinese medicinal oral liquid for treating colibacillosis of avian |
| 07/02/2008 | CN101209304A Chinese medicinal granule with clearing heat and detoxication, blood-nourishing and dysentery-stopping efficacy |
| 07/02/2008 | CN101209303A Chinese medicinal oral liquid with heat-clearing and detoxication, antimicrobial and anti-inflammation efficacy |
| 07/02/2008 | CN101209298A Chinese medicinal granule for treating infectious rhinitis of avian |
| 07/02/2008 | CN101209293A Chinese medicinal granule with heat-clearing, detoxication, wind-expelling and cold-expelling efficacy |
| 07/02/2008 | CN101209291A Chinese medicine injection for animals with heat-clearing, detoxication wind-heat-removing efficacy |
| 07/02/2008 | CN101209290A Chinese medicine injection for treating virosis of livestock |
| 07/02/2008 | CN101209286A Method for preparing forsythol from forsythia suspensa leaves |
| 07/02/2008 | CN101209282A Preparation method of composite traditional Chinese medicine preparation for treating acquired immuno-deficiency syndrome |
| 07/02/2008 | CN101209271A Medicinal composition for preventing helicobacter pylori |
| 07/02/2008 | CN101209258A Immunopotentiator and antiviral composition for animal |
| 07/02/2008 | CN101209255A Forsythiaside injection preparations and preparation thereof |
| 07/02/2008 | CN101209252A Use of aloperine in preparing medicament for treating chronic hepatitis B |
| 07/02/2008 | CN101209244A Method for producing acetylkitasamycin microcapsule type powder |
| 07/02/2008 | CN100398653C Novel streptococcus antigens |
| 07/02/2008 | CN100398555C Protease inhibitors for coronaviruses and SARS-COV and the use thereof |
| 07/02/2008 | CN100398542C Substituted 1,2,3- triazolepyridine compound with HIV-resistant activity, preparation method and uses |
| 07/02/2008 | CN100398535C Piperidine derivatives and their use as modulators of chemokine receptor activity especially CCR5 |
| 07/02/2008 | CN100398519C Tetracyclic benzamide derivatives and methods of use thereof |
| 07/02/2008 | CN100398149C Application of human sDR5 protein as medicine to treat virus hepatitis B |
| 07/02/2008 | CN100398136C Medicated pendant for preventing and treating common cold |
| 07/02/2008 | CN100398133C Chinese medicine for treating silkworm disease |
| 07/02/2008 | CN100398124C Medicine for treating chronic hepatitis and its preparing method |
| 07/02/2008 | CN100398111C Powder placed inside shoes for treating foot odor and beriberi |
| 07/02/2008 | CN100398109C Steroid derived antibiotics |
| 07/02/2008 | CN100398097C Siji sanhuang new preparation and preparing method and application |
| 07/01/2008 | US7393944 Lymphocytes; transcription factors; interferons |
| 07/01/2008 | US7393933 Hepatitis B monoclonal antibodies |
| 07/01/2008 | US7393928 Recombinant gelatins |
| 07/01/2008 | US7393859 Amide substituted imidazoquinolines |
| 07/01/2008 | US7393855 Treating human herpes virus, human immunodeficiency virus, and hepatitis B virus; optionally administered with other antiviral agents; (E)-9-{[2,2-bis-(hydroxymethyl)cyclopropylidene]methyl}adenine |
| 07/01/2008 | US7393849 N-[4-Amidinobenzoyl]-N-[3-phenoxybenzyl]-3-(4-biphenyl)-alanyl-glycyl-amide; anticarcinogenic, antidiabetic, anticholesterol agent, cardiovascular disorders, osteoporosis |
| 07/01/2008 | US7393831 prophylactic and therapeutic vaccination directed against the hepatitis C virus |
| 07/01/2008 | US7393824 Methods of peptide preparation |
| 07/01/2008 | US7393541 Mycobacterial vaccine |
| 07/01/2008 | US7393540 Therapeutic peptide for prevention of microorganismal infections; enzyme inhibitors; RNA inteference; antisense agents |
| 07/01/2008 | US7393539 Therapeutic agent for prevention and treatment of bacterial infection; bactericides; genetic vaccines; immunotherapy |
| 07/01/2008 | US7393536 Nucleotide sequences coding streptococcus capsular polysaccharide antigens for use in diagnosis and prevention of infections in mammals; veterinary medicine |
| 07/01/2008 | US7393535 Adjuvants for use in vaccines |
| 06/29/2008 | CA2601963A1 Method of enriching glucoraphanin in radish seed preparations |
| 06/26/2008 | WO2008077130A2 Homogeneous paste and gel formulations |
| 06/26/2008 | WO2008077103A1 Preperation and utility of ccr5 inhibitors |
| 06/26/2008 | WO2008076261A2 Water-soluble phenicol prodrugs in a lipophilic vehicle system |
| 06/26/2008 | WO2008076259A1 Water-soluble prodrugs of florfenicol and its analogs |
| 06/26/2008 | WO2008076256A1 Water-soluble prodrugs of chloramphenicol, thiamphenicol, and analogs thereof |
| 06/26/2008 | WO2008076225A2 Non-nucleoside reverse transcriptase inhibitors |
| 06/26/2008 | WO2008076223A1 Non-nucleoside reverse transcriptase inhibitors |
| 06/26/2008 | WO2008075684A1 Antibiotic glycopeptide derivative |
| 06/26/2008 | WO2008075462A1 Helicobacter pylori eradicating agent having inhibitory activity on gastric acid secretion |
| 06/26/2008 | WO2008075103A1 Antiviral indoles |
| 06/26/2008 | WO2008075070A1 Sulfonamide derivatives for therapeutic use as fatty acid synthase inhibitors |
| 06/26/2008 | WO2008074895A1 Circular ccr5 peptide conjugates and uses thereof |
| 06/26/2008 | WO2008074230A1 Interferon alpha mutant and its polyethylene glycol derivative |
| 06/26/2008 | WO2008074079A1 Identification of candidate vaccine antigens from dichelobacter nodosus |
| 06/26/2008 | WO2008043829A3 Method for treating hiv-1 infection by the combined administration of nevirapine, tenofovir and emtricitabine |
| 06/26/2008 | WO2008043733B1 3- (benzo [d] [1,3] dioxol-5-ylmethyl) -4- (thio) oxo-2- (thio) oxo-azolidin-5-ylidene derivatives as antibacterial agents |
| 06/26/2008 | WO2008035243A3 Composition for treatment of burns and wounds |
| 06/26/2008 | WO2008014311A3 Inhibitors of undecaprenyl pyrophosphate synthase |
| 06/26/2008 | WO2008011521A3 Polycyclic viral inhibitors |
| 06/26/2008 | WO2007075605A3 Use of beta-hydroxy-beta-methylbutyrate to modulate the imbalance in type and type 2 cytokine production |
| 06/26/2008 | US20080154030 combining niacin or niacinamide in the aqueous fluid with the cyclodextrin derivative; solubilizers |
| 06/26/2008 | US20080153905 Esters of 2-phenylalkanenitriles and antifungal compositions containing them |
| 06/26/2008 | US20080153899 Fatty amine drug conjugates |
| 06/26/2008 | US20080153895 Macrocyclic indole compounds, e.g., 16-cyclohexyl-3,6-dimethyl-17-phenyl-4,5,6,7,8,9-hexahydro-1H-13,15-(ethanediylidene)pyrrolo[2,1-f][1,2,7,10,13]thiatetraazacyclohexadecine-2,12(3H)-dione 10,10-dioxide; hepatitis C virus polymerase inhibitors |
| 06/26/2008 | US20080153894 Cyclooxygenase-2 inhibitor and antibacterial agent combination for intramammary treatment of mastitis |
| 06/26/2008 | US20080153783 Pyrimidyl Phosphonate Antiviral Compounds and Methods of Use |
| 06/26/2008 | US20080153772 Oligonucleotides For Rna Interference and Biological Applications Thereof |
| 06/26/2008 | US20080153748 Antimicrobial polypeptides; topical applying a fungicide biodrug for treating nail infections and athlete's foot |
| 06/26/2008 | US20080153742 Fas peptide mimetics and uses thereof |
| 06/26/2008 | US20080153131 Free of transmembrane domain; immunoglobulins; autoimmune diseases |
| 06/26/2008 | US20080153108 identifying Francisella tularensis vaccine candidates. It enables identification of novel vaccine candidates and quality assurance for vaccine batches, assessment of protection in vaccinates and identification of the infecting agent in vaccinates. Mice were first vaccinated with Brucella infections |
| 06/26/2008 | US20080152735 Herbal Extract Having Anti- Influenza Virus Activity and Preparation of Same |
| 06/26/2008 | US20080152729 Plant extracts; Leishmaniasis and Trypanosomaisis infections |
| 06/26/2008 | US20080152724 Treatment of periodontitis with an injectable slow release iodine |
| 06/26/2008 | US20080152701 Methods and Compositions for the Treatment and Prevention of Staphylococcus Infections |
| 06/26/2008 | US20080152697 Controlled release of an antimicrobial complex containing silver ion, zirconium, titanium or hafnium, lithium, sodium or potassium, phosphate and hydrogen that maintains its antiseptic effectiveness |
| 06/26/2008 | US20080152670 Attenuated; comprising at least two types of foreign genes inserted to allow expression into two different regions in a recombinant feline herpesvirus type 1 genome; one region encodes thymidine kinase; no lethal effect on the proliferation of the virus in the feline herpesvirus 1 genome |
| 06/26/2008 | US20080152658 Vaccine for use in prevention and treatment of hepatitis-B infection |